Skip to main content
Signal8

NEWELL WILLIAM J

SEC insider (Form 3/4/5 filer). CIK 0001309660. CEO at SUTRO BIOPHARMA, INC. (STRO). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies NEWELL WILLIAM J has filed insider reports for

  • SUTRO BIOPHARMA, INC. (STRO): Director, Officer, CEO
NEWELL WILLIAM J profile photo

NEWELL WILLIAM J

CIK: 0001309660

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (57.1%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SUTRO BIOPHARMA, INC. logo
STRO

SUTRO BIOPHARMA, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 5, 2025
    Exercise
    Direct
    18.8K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 5, 2025
    Tax Payment
    Direct
    6.7K shares at avg. $1.36$9K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 4, 2025
    Tax Payment
    Direct
    11.1K shares at avg. $1.42$16K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 4, 2025
    Exercise
    Direct
    31.1K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2025
    Tax Payment
    Direct
    25.2K shares at avg. $1.59$40K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2025
    Exercise
    Direct
    23.8K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 1, 2025
    Exercise
    Direct
    41.8K shares-

1-7 of 7